FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to medicine, namely to therapy and pharmaceutics, and deals with an influence on the functional activity of a cannabinoid receptor. For this purpose an activated-potentiated form of antibodies to the human cannabinoid receptor is introduced into an organism with the application of an activated-potentiated form of antibodies to an intact molecule or a polypeptide fragment of the human cannabinoid receptor of type I.
EFFECT: method ensures the effective correction of endocannabinoid system impairments with the absence of side effects.
4 cl, 1 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATING OBESITY AND ASSOCIATED METABOLIC DISORDERS | 2013 |
|
RU2582393C2 |
| METHOD OF TREATING OBESITY AND ACCOMPANYING METABOLIC DISORDERS AND MEDICATION FOR TREATING OBESITY AND ACCOMPANYING METABOLIC DISORDERS | 2010 |
|
RU2552221C2 |
| MEDICATION BASED ON SUBSTANCE INFLUENCING ENDOCANNABINOID SYSTEM | 2013 |
|
RU2568896C2 |
| METHOD OF TREATING PATHOLOGICAL SYNDROME AND DRUG OF CENTRAL AND PERIPHERAL ACTION FOR TREATING PATHOLOGICAL SYNDROME | 2011 |
|
RU2610438C2 |
| METHOD OF TREATING CHRONIC CARDIAC FAILURE AND PHARMACEUTICAL COMPOSITION FOR TREATING CHRONIC CARDIAC FAILURE | 2011 |
|
RU2523451C2 |
| METHOD OF TREATMENT AND PREVENTION OF ARTERIAL HYPERTENSION AND PHARMACEUTICAL COMPOSITION FOR TREATMENT OF ARTERIAL HYPERTENSION | 2010 |
|
RU2525156C2 |
| METHOD OF TREATING CHRONIC HEART FAILURE AND PHARMACEUTICAL COMPOSITION FOR COMPLEX THERAPY OF CHRONIC HEART FAILURE | 2010 |
|
RU2525155C2 |
| METHOD OF TREATING VEGETOVASCULAR DYSTONIA AND PHARMACEUTICAL COMPOSITION FOR TREATING VEGETOVASCULAR DYSTONIA | 2010 |
|
RU2523557C2 |
| MEDICINE FOR BIRD INFLUENZA TREATMENT | 2007 |
|
RU2332236C1 |
| NEUROTROPIC DRUG AND METHOD OF TREATING STRUCTURAL DISEASES OF NERVOUS SYSTEM, PSYCHOORGANIC SYNDROME AND ENCEPHALOPATHIES OF VARIOUS ORIGINS | 2011 |
|
RU2536234C2 |
